Ctn(Crotalicidin)

General Information


DRACP ID  DRACP00582

Peptide Name   Ctn(Crotalicidin)

Sequence  KRFKKFFKKVKKSVKKRLKK工FKKPMVIGVTIPF

Sequence Length  34

UniProt ID  Not available

PubChem CID  Not available

Origin  Rattlesnake Venom Cathelicidin

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa S3 Breast cancer Carcinoma IC50 < 1 µM Resazurin assay 4h 1
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia IC50 < 1 µM Resazurin assay 4h 1
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia IC50=1.56 µM Resazurin assay 4h 1
HL-60 Adult acute myeloid leukemia; Acute myeloid leukemia Leukemia IC50>12.5 µM Resazurin assay 4h 1
Jurkat E6.1 Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia IC50>12.5 µM Resazurin assay 4h 1

Hemolytic Activity  Human erythrocytes: 7% and 33% hemolysis at 100 and 400 μM, respectively

Normal (non-cancerous) Cytotoxicity  MM6: IC50=3.12 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C197H332N52O35S

Absent amino acids  ACDEHNQWY

Common amino acids  K

Mass  460995

Pl  12.66

Basic residues  15

Acidic residues  0

Hydrophobic residues  12

Net charge  15

Boman Index  -5885

Hydrophobicity  -56.76

Aliphatic Index  68.53

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26465972

Title  Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity

Doi 10.1021/acs.jmedchem.5b01142

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.